About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD42.63
- USD44.07
- USD42.28
- USD45.48
- 17.20%
- 127M
- 2.46M
- 3.00M
- 8.5B
- 21.72
- 76.00%
Stock News
2 hours ago
Dow Jones Futures: Trump Tariffs Back In Focus; Tesla Rival Uber Leads 5 Stocks In Buy Zones
Yahoo
9 hours ago
Happiness researcher shares his '90-second rule' to live a better, more fulfilled life—it helps when you're angry or upset
CNBC
10 hours ago
Retirees are flocking to these 10 U.S. states—No. 1 offers low taxes and sunny weather
CNBC
11 hours ago
Fast-casual restaurants lean on loyalty programs to offset consumer pullback
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
